GNPX Stock Analysis: Buy, Sell, or Hold?
GNPX - Genprex, Inc. Common Stock
$0.48
-0.05 (-9.81%)
▼
5d:
-18.32%
30d:
-26.15%
90d:
-60.11%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When GNPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GNPX is down 18.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GNPX is down 18.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GNPX is currently trading at $0.48, which is considered oversold relative to its 30-day fair value range of $0.49 to $0.62.
Technical Outlook: Technically, GNPX is in a strong downtrend. The price is currently testing key support at $0.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: GNPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.50 (+1301.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNPX is in a strong downtrend. The price is currently testing key support at $0.63. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.8% recently.
Market Sentiment: GNPX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.50 (+1301.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.49 -
$0.62
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.8%)
- BULLISH: Trading 1301.3% below Wall St target ($7.50)
- WARNING: Recommendation downgraded due to -18.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.49 -
$0.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.63
Resistance Level
$0.81
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$7.50
(+1301.3%)
Share & Embed Analysis
Last updated: July 14, 2026 1:00 PM ET
Data refreshes hourly during market hours. Next update: 2:00 PM
Data refreshes hourly during market hours. Next update: 2:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brent M Longnecker
SELL
8 shares
2026-04-14
Brent M Longnecker
SELL
10 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 57 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 63 BUY |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$82 | 58 HOLD |
